Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis

NCT ID: NCT04395040

Last Updated: 2021-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-08

Study Completion Date

2020-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A third of cancers are diagnosed in patients over 75 years of age. There are fears of the elderly talking about new symptoms. The doctor may find himself trapped by general symptoms, which can be confused with "normal aging".

Some older, younger people have lived in a world where cancer was little talked about, where there was little treatment possible.

There is an idea that doctors are not very quick to start curative treatment because they think that the elderly cannot bear it.

It is important to differentiate screening and early diagnosis.

Delayed treatment causes a decrease in survival and quality of life. Cancer can be discovered suddenly: for example, occlusion with peritonitis in case of a stenosing colonic tumor, leading to urgent management.

The elderly are often excluded from clinical studies.

In addition, the geriatric population is heterogeneous, leading to very diverse and individual care, with prioritization of issues.

Oncogeriatrics, which combines two services (oncology and geriatrics), is a specialized discipline, promoting comprehensive care for the elderly patient with cancer.

The general practitioner is at the center of care. It detects early signs and starts examinations if necessary.

Cancer care can be divided up with the different stages of care with various teams, including organ specialists.

The general practitioner is the privileged interlocutor for the patient and their family (medico-psycho-social plan), who knows their history and their experience.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Elderly patients with digestive cancer or breast cancer.

Semi-structured interview

Intervention Type OTHER

Semi-structured interview

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Semi-structured interview

Semi-structured interview

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 75 years old (terminal included)
* Incident diagnosis
* Has cancer whose diagnosis dates back more than 3 months
* Digestive cancer, breast cancer
* Stage of advanced cancer (TNM stage: T\> T2 (terminal included), M1)
* According to the opinion of the oncogeriatrician on the time of taking charge
* Follow-up of a geriatrics service, onco-geriatrics orientation
* Living in the Rhône department
* Non-opposition of the patient to the study

Exclusion Criteria

* Cancer diagnosis more than 6 months old
* Patient denies
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Camille TAZELMATI, MD Student

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon

Marie VALERO, MD

Role: STUDY_DIRECTOR

Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Léon Bérard

Lyon, , France

Site Status

Hôpital Lyon Sud

Pierre-Bénite, , France

Site Status

Centre hospitalier Fleyriat

Viriat, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL19_0731

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assessment Tool for Older Patients With Cancer
NCT00477958 ACTIVE_NOT_RECRUITING NA